France Intragastric Balloon Market Insight
Published: 29 July 2026 | Report Format: Electronic (PDF) | Author: Sanket and Pranali
France intragastric balloon market is expected to experience an increase at a rate of 6.18% owing to high adoption rates of minimally invasive bariatric procedures, increased need for non-surgical obesity management, growth in healthcare expenditure, and rising prevalence of metabolic disorders.
France Intragastric Balloon Market Insights Forecasts to 2035
- The France Intragastric Balloon Market Size Was Estimated USD 34.2 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.18% from 2025 to 2035
- The France Intragastric Balloon Market Size is Expected to rise around USD 62.3 Million by 2035
Notable Insights for the France Intragastric Balloon Market
- The product-based segmentation indicates that the Swallowable Gas-Filled & Fluid-Filled Intragastric Balloons segment holds a commanding position with almost 56% market share in the France Intragastric Balloon Market in 2025 due to its growing usage in outpatient bariatric care, reduced patient recovery times, and non-endoscopic placement options.
- The application-based segmentation shows that the Hospitals & Specialized Bariatric Clinics segment dominates with a market share of almost 62% in the France Intragastric Balloon Market in 2025 as a result of increased adoption of multidisciplinary weight management protocols and advanced gastroenterology diagnostic facilities.
- The global revenue for Apollo Endosurgery, Inc. (a subsidiary of Boston Scientific Corporation) in fiscal year 2025 was estimated at about $1.15 billion, driven by rising demand for endobariatric devices, weight loss solutions, and minimally invasive therapeutic gastroenterology tools.
- As per expectations, rising outpatient procedure preferences and digital health tracking integration along with clinical safety advancements will drive market expansion in which intragastric balloon technology increases excess weight loss efficacy up to 38% and reduces metabolic comorbidity risks up to 26%.
Download the eBook (ToC)
Research Methodologies Used to Analyze the France Intragastric Balloon Market
The France intragastric balloon market is analyzed by a blend of primary and secondary research approaches for ensuring accurate information about the market and its forecasted performance. Primary research is conducted through discussions with medical device manufacturers and distributors, bariatric clinics, healthcare organizations, gastroenterologists, and experts to analyze demand trends, technological progress, and competitive activities. Secondary research will involve analyzing reports published by companies and governments, industry journals, clinical publications, medical trade data, and industry organizations in connection with minimally invasive surgery and bariatric device industries. Market estimation, trend analysis, and forecasting methods will be used for estimating market size, growth opportunities, price dynamics, and investments.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France Intragastric Balloon Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in France Intragastric Balloon Market
- Allurion Technologies Inc.
- Boston Scientific Corporation (Apollo Endosurgery, Inc.)
- ReShape Lifesciences Inc.
- Spatz Medical
- Silimed
- PlenSat Inc.
- Endalis
- Distrimed
- Lexel Medical
- Medsil (CSC Medicentral)
Recent Developments:
- In January 2026, Allurion Technologies Inc. partnered with leading private clinical networks in France to expand access to its swallowable, procedureless intragastric balloon program integrated with AI-driven virtual care platforms.
- In August 2025, Boston Scientific Corporation launched its next-generation liquid-filled adjustable intragastric balloon system in France, optimized for extended weight loss duration and enhanced patient tolerance.
Market Segmentation:
France Intragastric Balloon Market, By Product Type
- Single Intragastric Balloons
- Dual Intragastric Balloons
- Triple Intragastric Balloons
- Swallowable Intragastric Capsules
- Adjustable Intragastric Balloon Systems
France Intragastric Balloon Market, By Filling Material
- Fluid-Filled Balloons
- Gas-Filled Balloons
France Intragastric Balloon Market, By Application
- Moderate Obesity Management (BMI 30-35)
- Severe Obesity Pre-Surgical Intervention
- Metabolic Syndrome Treatment
France Intragastric Balloon Market, By End User
- Hospitals
- Specialized Bariatric & Gastroenterology Clinics
- Ambulatory Surgical Centers (ASCs)
Expert Views:
The growth of intragastric balloon markets in France will be facilitated by increased use of minimally invasive weight-loss solutions, increasing prevalence of obesity and diabetes, and higher demand for non-surgical bariatric treatments. The use of procedureless swallowable technology, integrated digital coaching platforms, and adjustable volume balloons will contribute to improved efficiency in treatment and enhanced demand in hospitals, bariatric clinics, ambulatory centers, metabolic care centers, and private clinical networks in France.
Author: Sanket and Pranali By Decisions Advisors and Consulting